Professor Lingjun Li and lab members reveal the crucial role of neuropeptides in cocaine addiction, paving the way for novel therapies.
Research
New NIH Grant to Fight Triple-Negative Breast Cancer
With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
New Grant Fuels Pediatric Brain Cancer Treatments
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
UW Researchers Find Links Between Microbial Bile Acids and the Risk of Colon Cancer
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.
Platelets as Protein Degraders
A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.
Addressing a Silent Threat to Seniors
Groundbreaking research from School of Pharmacy faculty reveals alarming misuse of OTC medications by older adults and offers a simple solution.
Three Research Forward Awards Fuel Faculty Innovation
Professors Timothy Bugni, Lingjun Li, and Weiping Tang have received UW–Madison grants to advance their innovative multidisciplinary research.
Tagged for Destruction
Professor Weiping Tang creates a new type of molecule to tag proteins on the surface of cancer cells for degradation.
Patents and Progress
Alumna Heidi Mansour (BS ‘96, PhD ’03), member of the National Academy of Inventors, aims to revolutionize lung and brain drug delivery.
Breaking Bad Chemistry
Through a National Institute of Justice grant, Assistant Professor Heather Barkholtz aims to tease out the toxicological difference between mirror-image meth isomers.